Hydrogel‐Based Slow Release of a Receptor‐Binding Domain Subunit Vaccine Elicits Neutralizing Antibody Responses Against SARS‐CoV‐2-Reference-Cited by-同舟云学术

Hydrogel‐Based Slow Release of a Receptor‐Binding Domain Subunit Vaccine Elicits Neutralizing Antibody Responses Against SARS‐CoV‐2

Published:2021-10-14 Issue:51 Volume:33 Page:2104362
ISSN:0935-9648
Container-title:Advanced Materials
language:en
Short-container-title:Advanced Materials

Author:

Gale Emily C.¹,Powell Abigail E.¹²,Roth Gillie A.³,Meany Emily L.³,Yan Jerry³,Ou Ben S.³,Grosskopf Abigail K.⁴,Adamska Julia⁵⁶,Picece Vittoria C. T. M.⁷⁸,d'Aquino Andrea I.⁷,Pulendran Bali²⁵⁶⁹,Kim Peter S.¹²¹⁰,Appel Eric A.²³⁶⁷¹¹^ORCID

Affiliation:

1. Department of Biochemistry Stanford University School of Medicine Stanford CA 94305 USA

2. Stanford ChEM‐H Stanford University Stanford CA 94305 USA

3. Department of Bioengineering Stanford University Stanford CA 94305 USA

4. Department of Chemical Engineering Stanford University Stanford CA 94305 USA

5. Department of Microbiology & Immunology Stanford University School of Medicine Stanford CA 94305 USA

6. Institute for Immunity, Transplantation, & Infection Stanford University School of Medicine Stanford CA 94305 USA

7. Department of Materials Science & Engineering Stanford University Stanford CA 94305 USA

8. Department of Chemistry and Applied Biosciences ETH Zurich Zurich 8093 Switzerland

9. Department of Pathology Stanford University School of Medicine Stanford CA 94306 USA

10. Chan Zuckerberg Biohub San Francisco CA 94158 USA

11. Department of Pediatrics–Endocrinology Stanford University School of Medicine Stanford CA 94305 USA

Funder

Bill and Melinda Gates Foundation

Stanford Maternal and Child Health Research Institute

National Science Foundation

National Institutes of Health

Publisher

Wiley

Subject

Mechanical Engineering,Mechanics of Materials,General Materials Science

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/adma.202104362

Reference52 articles.

1. World Health Organization WHO Coronavirus Disease (COVID‐19) Dashboard (2020) (accessed: May2021).

2. Covid-19: four fifths of cases are asymptomatic, China figures indicate

3. Evolution of the COVID-19 vaccine development landscape

4. Developing a low-cost and accessible COVID-19 vaccine for global health

Cited by 63 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Coronavirus spike protein-based vaccines. Vaccine delivery systems;Medicine in Drug Discovery;2024-09

2. Affinity-independent memory B cell origin of the early antibody-secreting cell response in naive individuals upon SARS-CoV-2 vaccination;Immunity;2024-09

3. Saponin nanoparticle adjuvants incorporating Toll-like receptor agonists drive distinct immune signatures and potent vaccine responses;Science Advances;2024-08-09

4. A tea polyphenol-loaded cellulose/silk fibroin/polyacrylic acid hydrogel for wound healing;Cellulose;2024-08-05

5. Vaccine delivery systems and administration routes: Advanced biotechnological techniques to improve the immunization efficacy;Vaccine: X;2024-08